RET and cancer: In addition, several studies have provided strong evidence that IF1 is highly overexpressed in primary samples of human colon, lung, breast and ovarian cancer compared with their normal tissue counterparts,114 thus suggesting a potential mechanism controlling RET in cancer cells.